Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Pricing and reimbursement in U.S
In clinical trials, it has demonstrated significant weight loss effects, leading to its FDA approval for the following indication and usage: WEGOVY is a glucagon-like peptide-1 receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in: adult patients with an initial body mass index of 30 kg/m2 or greater or 27 kg/m2 or greater in the presence of at least one weight-related comorbid condition
During your treatment, a registered nurse will administer the infusion while you relax comfortably in our clinic
Lpez-Pedrouso, M., Borrajo, P., Pateiro, M., Lorenzo, J
US$ 27.33
US$ 21.55
US$ 22.03
US$ 29.60
